EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old



Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old



Family Practice 22(5): 485-489



Airflow obstruction in smokers is often diagnosed relatively late. Earlier detection of airflow obstruction and smoking cessation may result in significant health gain. To determine the prevalence of previously undetected persistent airflow obstruction according to WHO/GOLD criteria in male smokers aged 40 to 65 years and its correlation with age, smoking history and the presence of coughing. In a cross-sectional study among 805 male smokers aged 40-65 years spirometry was performed according to ATS recommendations. In participants with low lung function (FEV1 < 85% predicted) a bronchodilator test was performed. In 702 participants [mean age 50 years (SD 6.6), mean number of pack years 24.7 (SD 9.6)] with acceptable spirometric curves, previously undetected airflow obstruction was found in 210 subjects (29.9%; 95% CI 26.5-33.4): mild airflow obstruction (GOLD stage 1) in 182 subjects (25.9%; 22.7-29.3) and moderate airflow obstruction (GOLD stage 2) in 28 (4.0%; 2.7-5.7). In the older age group (>55 years) airflow obstruction (GOLD 1 or higher) was found in 45% versus 21% in the youngest age group (40-44 years). In subjects with > or =30 pack years the prevalence of airflow obstruction was 45% versus 20% among those with <20 pack years. In smokers reporting coughing the prevalence was 47% versus 25% in those not reporting this symptom. The prevalence of undetected persistent airflow obstruction in middle-aged smokers is high. Targeted screening therefore, especially in smokers aged 40-65 years needs to be considered.

(PDF same-day service: $19.90)

Accession: 050003411

Download citation: RISBibTeXText

PMID: 15964866

DOI: 10.1093/fampra/cmi049



Related references

Female Smokers Are at Greater Risk of Airflow Obstruction Than Male Smokers. UK Biobank. American Journal of Respiratory and Critical Care Medicine 195(9): 1226-1235, 2017

Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. European Respiratory Journal 36(6): 1259-1269, 2011

Prevalence and correlates of airflow obstruction in ∼317,000 never-smokers in China. European Respiratory Journal 44(1): 66-77, 2015

Variability of the prevalence of undiagnosed airflow obstruction in smokers using different diagnostic criteria. Chest 133(1): 42-48, 2007

Airways reactivity, atopy and bronchoalveolar lavage in male smokers with airflow obstruction. Respiration; International Review of Thoracic Diseases 63(4): 199-204, 1996

Prevalence of airflow obstruction according GOLD, ATS and ERS criteria in symptomatic ever-smokers referring to a pulmonary rehabilitation department. Monaldi Archives for Chest Disease 75(3): 157-161, 2012

Lung function decline in male heavy smokers relates to baseline airflow obstruction severity. Chest 142(6): 1530-1538, 2013

Prevalence of Airflow Obstruction in U.S. Adults Aged 40-79 Years: NHANES Data 1988-1994 and 2007-2010. Copd 12(4): 355-365, 2016

Don't Forget Symptomatic Smokers without Airflow Obstruction. Annals of the American Thoracic Society 14(5): 615-616, 2017

Non-reversible airflow obstruction in non-smokers with asthma. European Respiratory Journal 12(Supplement 29): 11s, December, 1998

Estimating population prevalence of potential airflow obstruction using different spirometric criteria: a pooled cross-sectional analysis of persons aged 40-95 years in England and Wales. Bmj Open 4(7): E005685-E005685, 2014

Sex differences in emphysema phenotype in smokers without airflow obstruction. European Respiratory Journal 33(6): 1320-1328, 2009

Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction. Copd 13(2): 224-234, 2015

Capsaicin cough sensitivity in smokers with and without airflow obstruction. Respiratory Medicine 103(5): 786-790, 2010

Small airway dimensions in smokers with obstruction to airflow. American Review of Respiratory Disease 142(3): 563-570, 1990